Prof. Dr. Michael Hoffmeister
Stellvertretender Abteilungsleiter, Gruppenleiter
Stellvertretender Abteilungsleiter
Gruppenleiter "Molekularpathologische Epidemiologie"
Forschungsschwerpunkte
Klinische und Translationale Krebsepidemiologie
Darmkrebsprävention
Screening & Früherkennung
Risikofaktoren und prognostische Faktoren
Molekularpathologische Epidemiologie
Wissenschaftliche Studien, Projekte
Studien-/ Verbundleiter: PEARL-Studie, PEARL-Verbund, DACHS-Studie, PROSURV-Verbund, IMPACT-3 Verbund, BLITZ-Studie, IDA-Studie, KolosSal-Studie, ASTER 1|2-Studie
Co-PI: MiCCroBioTackle Consortium, 3D-PREDICT Cosnortium, GECCO Consortium, MOCCA
Weitere Studien und Projekte: UK Biobank, NAKO, DARIO-Studie, GEKKO-Studie, LEO-Studie
Weitere Aktivitäten und Mitgliedschaften
Helmholtz Health Prevention Task Force
ACED: International Alliance for Cancer Early Detection, Inequalities theme (Co-Lead)
NAKO: Nationale Kohorte, Expertengruppe Krebs
ECICC: European Commission Initiative on Colorectal Cancer
UNCAN.eu: a European initiative to better understand cancer
BBMRI: Biobanking and Biomolecular Resources Research Infrastructure
Promotionsausschuss (Dr. sc. hum.), Medizinische Fakultät, Universität Heidelberg
Aktuelle Postdocs und Doktoranden
Jie Ding - Postdoc
Durgesh Wankhede - Postdoc
Tanwei Yuan - Postoc
Elena Brena - PhD student
Mariem Hachani - PhD student
Toktam Pour - PhD student
Mary Jose Urruchúa Rodriguez - PhD student
Publikationen
Ausgewählte Publikationen der letzten Jahre
Wankhede D, Halama N, Kloor M, Brenner H, Hoffmeister M. Diabetes and Colorectal Cancer Risk and Survival According to Tumor Immunity Status. J Clin Oncol 2025. Online ahead of print.
Hoffmeister M, Seum T, Ludwig L, Brenner H. Performance of a smartphone-based stool test for use in colorectal cancer screening: population-based study. Clin Gastroenterol Hep 2025. Online ahead of print.
Wankhede D, Yuan T, Kloor M, Halama N, Brenner H, Hoffmeister M. Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2024;9(7):609-619.
Hoffmeister M, Cardoso R, Brenner H. Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. N Engl J Med 2023;388(4):377-378.
Hoffmeister M. Interim evaluation of the colorectal cancer screening programme in the Netherlands. Lancet Gastroenterol Hepatol 2022;7(1):8-9.
Cardoso R, ..., Hoffmeister M, Brenner H. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol 2021;22(7):1002-1013.
Hoffmeister M, Brenner H, Amitay EL. Smoking Is Consistently Associated With Major Molecular Subtypes of Colorectal Cancer. Am J Gastroenterol 2021;116(5):1092-1093.
Hoffmeister M, Bläker H, Jansen L, Alwers E, Amitay EL, Carr PR, Kloor M, Herpel E, Roth W, Chang-Claude J, Brenner H. Colonoscopy and Reduction of Colorectal Cancer Risk by Molecular Tumor Subtypes: A Population-Based Case-Control Study. Am J Gastroenterol 2020;115(12):2007-2016.
Kather JN, Pearson AT, Halama N, Jäger D, Krause J, Loosen SH, Marx A, Boor P, Tacke F, Neumann UP, Grabsch HI, Yoshikawa T, Brenner H, Chang-Claude J, Hoffmeister M, Trautwein C, Luedde T. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med 2019;25(7):1054-56.
Amitay EL, Carr PR, Jansen L, Walter V, Roth W, Herpel E, Kloor M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes. J Natl Cancer Inst 2019;111(5):475-83.
Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K; International Agency for Research on Cancer Handbook Working Group. The IARC Perspective on Colorectal Cancer Screening. N Engl J Med 2018;378(18):1734-40.
Carr PR, Weigl K, Jansen L, Walter V, Erben V, Chang-Claude J, Brenner H, Hoffmeister M. Healthy Lifestyle Factors Associated With Lower Risk of Colorectal Cancer Irrespective of Genetic Risk. Gastroenterology 2018;155(6):1805-15.